Inventor
Lichun WANG
Inventor
CN
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides12%
C07DHeterocyclic compounds8%
Y02ATechnologies for adaptation to climate change6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07BGeneral methods of organic chemistry3%
C12NMicroorganisms or enzymes3%
G06NComputing arrangements based on specific computational models2%
G06TImage data processing or generation, in general2%
PatentTitleYear
12,590,150Antibody against Nectin-4 and application thereof202612,150,944Use of anti-HER2 antibody-drug conjugate in cancer treatment202412,077,571Polyomavirus neutralizing antibodies202411,970,506Bioactive molecule conjugate, preparation method and use thereof202411,931,467Albumin pharmaceutical composition and preparation method therefor202411,911,460Lipid delivery system and virus-like structure (VLS) vaccine constructed therefrom202411,903,948Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof202411,798,264Dictionary learning method and means for zero-shot recognition202311,778,894Boron-containing organic light-emitting diode device and preparation method thereof202311,667,629Isoxazole derivative, preparation method therefor, and use thereof202311,655,295Anti-LAG-3 antibody and use thereof202311,639,378Polyomavirus neutralizing antibodies202311,541,049Tetrahydroisoquinoline derivatives, preparation process and use thereof202311,515,490Organic light-emitting composite material and an organic light-emitting device comprising the same202211,450,0663D reconstruction method based on deep learning202211,434,235Solid form of dihydropyrimidine compound and preparation method therefor and use thereof202211,421,029Recombinant bispecific antibodies to PD-L1 and CTLA-4202211,395,812Docetaxel albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereof202211,332,457Aromatic compound, pharmaceutical composition and use thereof202211,292,785Nitrogen-containing benzoheterocycle compound comprising carboxylic acid group, preparation method and use thereof202211,266,674Pharmaceutical composition for tumor treatment or prevention, method, and use thereof202211,261,170Aromatic compound, pharmaceutical composition and use thereof202211,207,420Cytotoxin and conjugate, uses of same and preparation method therefor202111,200,685Method for three-dimensional human pose estimation202111,186,599Phosphonamide ester compound, salt thereof, related crystal form thereof, preparation method therefor and use thereof202111,174,234Crystal form of 4-phenylthiazole derivative and preparation method thereof202111,161,894Polyomavirus neutralizing antibodies202111,154,511Albumin pharmaceutical composition and preparation method therefor202111,136,413PDL-1 antibody, pharmaceutical composition thereof, and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (15)· patent assignee history
2021–2024Patents assigned to SICHUAN KELUN PHARM RES INST CO LTD (4)· patent assignee history
2021–2024Patents assigned to NOVARTIS AG (3)· patent assignee history
2021–2023Patents assigned to UNIV BEIJING TECHNOLOGY (3)· patent assignee history
2021–2026Based in CN· patent location history
2022–2023Patents assigned to JIANGSU SUNERA TECH CO LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD | 15 | 2021–2024 |
| SICHUAN KELUN PHARM RES INST CO LTD | 4 | 2021–2024 |
| NOVARTIS AG | 3 | 2021–2024 |
| UNIV BEIJING TECHNOLOGY | 3 | 2021–2023 |
| JIANGSU SUNERA TECH CO LTD | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 29 | 2021–2026 |